Clinical Trials · NCT02824718
Recombinant Human rhPTH(1-34) VS Association Alfacalcidol/Hydrochlorothiazide in Severe Primary Hypoparathyroidism
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Enrollment
- 16
- Start date
- Jun 2017
- Locations
- 1 site, France
- Primary endpoint
- Plasma calcium concentration